Cassava Sciences, Inc. is a clinical-stage biotechnology company. The Company is focused on developing the drug for the treatment of neurodegenerative diseases, such as Alzheimers disease. The Company’s products include Simufilam and SavaDx. Its lead... Read more
1 hour ago
MarketWatch
1 hour ago
MarketWatch
1 hour ago
CNBC
1 hour ago
MarketWatch
More Stock Analysis & Reports
Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.